Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Sugino, Kazuhiro Yoshida, J. Bolodeoku., H. Tahara, I. Buley, S. Manek, C. Wells, S. Goodison, T. Ide, Toshimitsu Suzuki, E. Tahara, D. Tarin (1996)
Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspiratesInternational Journal of Cancer, 69
E. Nigg (2002)
Centrosome aberrations: cause or consequence of cancer progression?Nature Reviews Cancer, 2
T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Lønning, A. Børresen-Dale (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 98
Hai Yan, Weishi Yuan, V. Velculescu, B. Vogelstein, K. Kinzler (2002)
Allelic Variation in Human Gene ExpressionScience, 297
E. Lahoz, N. Liégeois, Pumin Zhang, J. Engelman, J. Horner, A. Silverman, Ronald Burde, M. Roussel, C. Sherr, S. Elledge, R. DePinho (1999)
Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In VivoMolecular and Cellular Biology, 19
J. Pollack, T. Sørlie, C. Perou, Christian Rees, S. Jeffrey, P. Lønning, R. Tibshirani, D. Botstein, A. Børresen-Dale, P. Brown (2002)
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumorsProceedings of the National Academy of Sciences of the United States of America, 99
M. Speicher, D. Ward (1996)
The coloring of cytogeneticsNature Medicine, 2
Ju He, JR Allen, VP Collins, M. Allalunis-Turner, R. Godbout, rd Day, C. James (1994)
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.Cancer research, 54 22
J. Haber (1999)
DNA recombination: the replication connection.Trends in biochemical sciences, 24 7
Peter Lichter (1997)
Multicolor FISHing: what's the catch?Trends in genetics : TIG, 13 12
G. Hampton, A. Larson, R. Baergen, R. Sommers, S. Kern, W. Cavenee (1996)
Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 93 13
Peter Jones, S. Baylin (2002)
The fundamental role of epigenetic events in cancerNature Reviews Genetics, 3
D. Albertson, B. Ylstra, R. Segraves, C. Collins, S. Dairkee, D. Kowbel, W. Kuo, J. Gray, D. Pinkel (2000)
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNature Genetics, 25
S. Lamprecht, M. Lipkin (2002)
Migrating colonic crypt epithelial cells: primary targets for transformation.Carcinogenesis, 23 11
K. Goss, M. Risinger, J. Kordich, M. Sanz, J. Straughen, Lisa Slovek, A. Capobianco, J. German, G. Boivin, J. Groden (2002)
Enhanced Tumor Formation in Mice Heterozygous for Blm MutationScience, 297
A. Pierce, Jeremy Stark, F. Araujo, M. Moynahan, M. Berwick, M. Jasin (2001)
Double-strand breaks and tumorigenesis.Trends in cell biology, 11 11
R. Wood, M. Mitchell, J. Sgouros, T. Lindahl (2001)
Human DNA Repair GenesScience, 291
W. Abdel-Rahman, Kanade Katsura, W. Rens, P. Gorman, D. Sheer, D. Bicknell, W. Bodmer, M. Arends, A. Wyllie, P. Edwards (2001)
Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangementProceedings of the National Academy of Sciences of the United States of America, 98
M. Muleris, R. Salmon, B. Dutrillaux (1990)
Cytogenetics of colorectal adenocarcinomas.Cancer genetics and cytogenetics, 46 2
Bichsel Ve, Liotta La, Petricoin rd (2001)
Cancer proteomics: from biomarker discovery to signal pathway profiling.Cancer journal, 7 1
Z. Weaver, C. Montagna, Xiaoling Xu, T. Howard, M. Gadina, S. Brodie, C. Deng, T. Ried (2002)
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancerOncogene, 21
M. Gorre, M. Mohammed, K. Ellwood, N. Hsu, R. Paquette, P. Rao, C. Sawyers (2001)
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 293
A Levitzki (2002)
Tyrosine kinases as targets for cancer therapyEur. J. Cancer, 38
L. Liotta, E. Petricoin (2000)
Molecular profiling of human cancerNature Reviews Genetics, 1
A. Bednarek, A. Sahin, A. Brenner, D. Johnston, Claudio Aldaz (1997)
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 1
A. Kallioniemi, O. Kallioniemi, D. Sudar, D. Rutovitz, J. Gray, F. Waldman, D. Pinkel (1992)
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.Science, 258 5083
D. Medina (2002)
Biological and molecular characteristics of the premalignant mouse mammary gland.Biochimica et biophysica acta, 1603 1
M. Tirkkonen, O. Johannsson, B. Agnarsson, Hampus Olsson, S. Ingvarsson, R. Karhu, M. Tanner, J. Isola, R. Barkardottir, Å. Borg, O. Kallioniemi (1997)
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.Cancer research, 57 7
J. Mendelsohn (2002)
Targeting the epidermal growth factor receptor for cancer therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 18 Suppl
Jeremy Henson, A. Neumann, T. Yeager, R. Reddel (2002)
Alternative lengthening of telomeres in mammalian cellsOncogene, 21
T. Kuukasjärvi, M. Tanner, S. Pennanen, R. Karhu, O. Kallioniemi, J. Isola (1997)
Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.The American journal of pathology, 150 4
Thomas Schmittgen (2002)
Real-Time Quantitative PCR
B. Bastian, M. Kashani-Sabet, H. Hamm, T. Godfrey, D. Moore, E. Bröcker, P. Leboit, D. Pinkel (2000)
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.Cancer research, 60 7
G. Hodgson, J. Hager, S. Volik, S. Hariono, M. Wernick, D. Moore, D. Albertson, D. Pinkel, C. Collins, D. Hanahan, J. Gray (2001)
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomasNature Genetics, 29
Saurabh Saha, A. Sparks, C. Rago, V. Akmaev, Clarence Wang, B. Vogelstein, K. Kinzler, V. Velculescu (2002)
Using the transcriptome to annotate the genomeNature Biotechnology, 20
D. Gent, J. Hoeijmakers, R. Kanaar (2001)
Chromosomal stability and the DNA double-stranded break connectionNature Reviews Genetics, 2
S. Artandi (2002)
Telomere shortening and cell fates in mouse models of neoplasia.Trends in molecular medicine, 8 1
D. Krause, R. Etten (2005)
Tyrosine kinases as targets for cancer therapy.The New England journal of medicine, 353 2
S. Linardopoulos, Santiago Silva, G. Klein, A. Balmain (2000)
Allele‐specific loss or imbalance of chromosomes 9, 15, and 16 in B‐cell tumors from interspecific F1 hybrid mice carrying eμ‐c‐myc or N‐myc transgenesInternational Journal of Cancer, 88
T. Lange, L. Shiue, R. Myers, D Cox, S Naylor, A Killery, H. Varmus (1990)
Structure and variability of human chromosome endsMolecular and Cellular Biology, 10
J. Baselga (2002)
Why the epidermal growth factor receptor? The rationale for cancer therapy.The oncologist, 7 Suppl 4
C. Ruivenkamp, T. Wezel, C. Zanon, A. Stassen, Č. Vlček, T. Csikós, A. Klous, N. Tripodis, A. Perrakis, L. Boerrigter, P. Groot, J. Lindeman, W. Mooi, Gerrit Meijjer, Gert Scholten, H. Dauwerse, V. Paces, N. Zandwijk, G. Ommen, P. Demant (2002)
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancersNature Genetics, 31
T. Lange (2002)
Protection of mammalian telomeresOncogene, 21
M. Morini, S. Astigiano, M. Mora, Cristina Ricotta, N. Ferrari, S. Mantero, G. Levi, M. Rossini, O. Barbieri (2000)
Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4Oncogene, 19
R. Rubin, M. Merchant (2000)
A rapid protein profiling system that speeds study of cancer and other diseases.American clinical laboratory, 19 8
D. Ichikawa, N. Hashimoto, M. Hoshima, T. Yamaguchi, K. Sawai, Y. Nakamura, Toshio Takahashi, T. Abe, J. Inazawa (1996)
Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancerCancer, 77
T. Ried, Regina Knutzen, R. Steinbeck, H. Blegen, E. Schröck, K. Heselmeyer, S. Manoir, G. Auer (1996)
Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumorsGenes, 15
J. Lukas, L. Aagaard, M. Strauss, J. Bartek (1995)
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.Cancer research, 55 21
Laleh Shayesteh, Yiling Lu, W. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, B. Powell, G. Mills, J. Gray (1999)
PIK3CA is implicated as an oncogene in ovarian cancerNature Genetics, 21
M. Nagai, L. Yamamoto, S. Salaorni, Mércia Pacheco, M. Brentani, Edson Barbosa, Ricardo Brentani, S. Mazoyer, Simon Smith, B.A.J Ponder, Lois Mulligan (1994)
Detailed deletion mapping of chromosome segment 17q12‐21 in sporadic breast tumoursGenes, 11
M. Bärlund, O. Monni, J. Kononen, R. Cornelison, Joachim Torhorst, Guido Sauter, Olli Kallioniemi, A. Kallioniemi (2000)
Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.Cancer research, 60 19
D. Slamon, W. Godolphin, L. Jones, J. Holt, Steven Wong, D. Keith, W. Levin, S. Stuart, J. Udove, A. Ullrich, M. Press (1989)
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.Science, 244 4905
D Hanahan, RA Weinberg (2000)
The hallmarks of cancerCell, 100
K. Khanna, MF Lavin, S. Jackson, TD Mulhern (2001)
ATM, a central controller of cellular responses to DNA damageCell Death and Differentiation, 8
Y. Remvikos, N. Vogt, M. Muleris, R. Salmon, B. Malfoy, B. Dutrillaux (1995)
DNA‐repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangementsGenes, 12
N. Galili, Richard Davis, W. Fredericks, Sunil Mukhopadhyay, F. Rauscher, B. Emanuel, G. Rovera, F. Barr (1993)
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcomaNature Genetics, 5
P. O’Connell, V. Pekkel, D. Allred, S. Fuqua, C. Osborne, G. Clark (1998)
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.Journal of the National Cancer Institute, 90 9
K. Nasmyth (2002)
Segregating Sister Genomes: The Molecular Biology of Chromosome SeparationScience, 297
T. Bocker, J. Rüschoff, R. Fishel (1999)
Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.Biochimica et biophysica acta, 1423 3
R. Lipshutz, S. Fodor, T. Gingeras, D. Lockhart (1999)
High density synthetic oligonucleotide arraysNature Genetics, 21 Suppl 1
M. Whitfield, G. Sherlock, A. Saldanha, J. Murray, C. Ball, K. Alexander, J. Matese, C. Perou, M. Hurt, P. Brown, D. Botstein (2002)
Identification of genes periodically expressed in the human cell cycle and their expression in tumors.Molecular biology of the cell, 13 6
B. Bastian, Ulrich Wesselmann, D. Pinkel, P. Leboit (1999)
Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.The Journal of investigative dermatology, 113 6
M. Utting, W. Werner, R. Dahse, J. Schubert, K. Junker (2002)
Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 1
S. Bekri, J. Adélaı̈de, Sandra Merscher, Sandra Merscher, J. Grosgeorge, F. Caroli-Bosc, D. Perucca-Lostanlen, P. Kelley, M. Pébusque, C. Theillet, Daniel Birnbaum, P. Gaudray (1997)
Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.Cytogenetics and cell genetics, 79 1-2
C. Vogel, M. Cobleigh, Debu Tripathy, John Gutheil, Lyndsay Harris, L. Fehrenbacher, D. Slamon, M. Murphy, William Novotny, M. Burchmore, Steven Shak, S. Stewart, Michael Press (2002)
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 3
(2013)
Comparative Genomic Hybridization: Implications of the
C Fauth, MR Speicher (2001)
Classifying by colors: FISH-based genome analysisCytogenet. Cell. Genet., 93
P. Hinds, S. Dowdy, E. Eaton, A. Arnold, R. Weinberg (1994)
Function of a human cyclin gene as an oncogene.Proceedings of the National Academy of Sciences of the United States of America, 91
J. Sudbø, A. Reith, O. Lingjaerde (2001)
Gene-expression profiles in hereditary breast cancer.The New England journal of medicine, 344 26
H. Imoto, S. Hirotsune, M. Muramatsu, K. Okuda, O. Sugimoto, V. Chapman, Y. Hayashizaki (1994)
Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning.DNA research : an international journal for rapid publication of reports on genes and genomes, 1 5
Jing Li, Clifford Yen, D. Liaw, K. Podsypanina, S. Bose, Steven Wang, J. Puc, C. Miliaresis, L. Rodgers, R. Mccombie, S. Bigner, B. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. Wigler, R. Parsons (1997)
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 275
L. Wessels, Tibor Welsem, A. Hart, L. Veer, M. Reinders, P. Nederlof (2002)
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.Cancer research, 62 23
X. Chen, M. Stroun, J. Magnenat, L. Nicod, A. Kurt, Jacqueline Lyautey, C. Lederrey, P. Anker (1996)
Microsatellite alterations in plasma DNA of small cell lung cancer patientsNature Medicine, 2
井本 広済 (1995)
Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning
S. Pelengaris, Michael Khan, G. Evan (2002)
Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 109
R. Tibbetts, D. Cortez, K. Brumbaugh, R. Scully, D. Livingston, S. Elledge, R. Abraham (2000)
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.Genes & development, 14 23
K. Gordon, H. Ireland, Meryl Roberts, K. Steeghs, J. McCaul, D. Macdonald, E. Parkinson (2003)
High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.Cancer research, 63 2
Homaira Nawroz, W. Koch, P. Anker, M. Stroun, D. Sidransky (1996)
Microsatellite alterations in serum DNA of head and neck cancer patientsNature Medicine, 2
Sridhar Ramaswamy, K. Ross, E. Lander, T. Golub (2003)
A molecular signature of metastasis in primary solid tumorsNature Genetics, 33
Ju He, Jeffrey Olson, C. James (1995)
Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.Cancer research, 55 21
S. Aebi, B. Kurdi-Haidar, Robert Gordon, B. Cenni, Hua Zheng, D. Fink, R. Christen, C. Boland, M. Koi, R. Fishel, Stephen Howell (1996)
Loss of DNA mismatch repair in acquired resistance to cisplatin.Cancer research, 56 13
H. Fisk, C. Mattison, M. Winey (2002)
Centrosomes and tumour suppressors.Current opinion in cell biology, 14 6
J. Baselga, L. Hammond (2002)
HER-Targeted Tyrosine-Kinase InhibitorsOncology, 63
S. Farag, K. Archer, K. Mrózek, J. Vardiman, A. Carroll, M. Pettenati, J. Moore, J. Kolitz, R. Mayer, R. Stone, R. Larson, C. Bloomfield (2002)
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.International journal of oncology, 21 5
Richard Davis, C. D’Cruz, M. Lovell, J. Biegel, F. Barr (1994)
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.Cancer research, 54 11
Gyungyub Gong, S. Devries, Karen Chew, Imok Cha, B. Ljung, Frederic Waldman (2001)
Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 8
I. Orlow, L. Lacombe, G. Hannon, M. Serrano, Inmaculada Pellicer, G. Dalbagni, V. Reuter, Zuo‐Feng Zhang, D. Beach, C. Cordon-Cardo (1995)
Deletion of the p16 and p15 genes in human bladder tumors.Journal of the National Cancer Institute, 87 20
O. Sieber, K. Heinimann, P. Gorman, H. Lamlum, M. Crabtree, C. Simpson, D. Davies, K. Neale, S. Hodgson, R. Roylance, R. Phillips, W. Bodmer, I. Tomlinson (2002)
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APCProceedings of the National Academy of Sciences of the United States of America, 99
JF Costello, C Plass, WK Cavenee (2002)
Restriction landmark genome scanningMethods Mol. Biol., 200
T. Schenk, J. Ackermann, Christoph Brunner, P. Schenk, N. Zojer, S. Roka, J. Drach (1997)
Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients.Chest, 111 6
N. Forsyth, W. Wright, J. Shay (2002)
Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again.Differentiation; research in biological diversity, 69 4-5
V. Jordan, M. Morrow (2002)
Chemoprevention of breast cancer: a model for change.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 1
P. May (2000)
Cell cycle control and cancer.Pathologie-biologie, 48 3
M. Vijver, Yudong He, L. Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber, J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, Tony Velde, H. Bartelink, S. Rodenhuis, E. Rutgers, S. Friend, René Bernards (2002)
A gene-expression signature as a predictor of survival in breast cancer.The New England journal of medicine, 347 25
V. Iyer, C. Horak, C. Scafe, D. Botstein, M. Snyder, P. Brown (2001)
Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBFNature, 409
K. Alitalo, M. Schwab, Charlene Lin, H. Varmus, J. Bishop (1983)
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 80 6
M. Greaves (1996)
Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?Trends in genetics : TIG, 12 4
X. Guan, P. Meltzer, W. Dalton, J. Trent (1994)
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissectionNature Genetics, 8
M. Fero, Erin Randel, K. Gurley, James Roberts, C. Kemp (1998)
The murine gene p27Kip1 is haplo-insufficient for tumour suppressionNature, 396
Steinbeck Rg (1998)
Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa.British Journal of Cancer, 77
S. Solinas‐Toldo, S. Lampel, S. Stilgenbauer, J. Nickolenko, A. Benner, H. Döhner, T. Cremer, P. Lichter (1997)
Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalancesGenes, 20
C. Fauth, M. Speicher (2001)
Classifying by colors: FISH-based genome analysisCytogenetic and Genome Research, 93
C. Paweletz, Lu Charboneau, V. Bichsel, N. Simone, T. Chen, J. Gillespie, M. Emmert-Buck, M. Roth, E. Petricoin, L. Liotta (2001)
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion frontOncogene, 20
K. Haigis, W. Dove (2003)
A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosityNature Genetics, 33
G. Zardo, M. Tiirikainen, C. Hong, A. Misra, B. Feuerstein, S. Volik, C. Collins, K. Lamborn, A. Bollen, D. Pinkel, D. Albertson, J. Costello (2002)
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsNature Genetics, 32
M. Bärlund, F. Forozan, J. Kononen, L. Bubendorf, Y. Chen, M. Bittner, J. Torhorst, P. Haas, C. Bucher, G. Sauter, O. Kallioniemi, A. Kallioniemi (2000)
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.Journal of the National Cancer Institute, 92 15
R. Seeger, G. Brodeur, H. Sather, A. Dalton, S. Siegel, K. Wong, D. Hammond (1985)
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.The New England journal of medicine, 313 18
W. Cavenee, W. Cavenee, T. Dryja, R. Phillips, W. Benedict, R. Godbout, B. Gallie, A. Murphree, L. Strong, Raymond White (1983)
Expression of recessive alleles by chromosomal mechanisms in retinoblastomaNature, 305
C. Horak, M. Mahajan, N. Luscombe, M. Gerstein, S. Weissman, Michael Snyder (2002)
GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysisProceedings of the National Academy of Sciences of the United States of America, 99
Dae-Sung Yoon, R. Wersto, Weibo Zhou, F. Chrest, E. Garrett, T. Kwon, E. Gabrielson (2002)
Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.The American journal of pathology, 161 2
Larry Thompson, D. Schild (2001)
Homologous recombinational repair of DNA ensures mammalian chromosome stability.Mutation research, 477 1-2
J. Bártková, J. Lukas, P. Guldberg, J. Alsner, A. Kirkin, J. Zeuthen, J. Bartek (1996)
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.Cancer research, 56 23
S. Artandi, R. DePinho (2000)
A critical role for telomeres in suppressing and facilitating carcinogenesis.Current opinion in genetics & development, 10 1
N. Lisitsyn, Natalya Lisitsyn, M. Wigler (1993)
Cloning the differences between two complex genomesScience, 259
R. Willenbucher, D. Aust, Cornell Chang, Suzanne Zelman, L. Ferrell, D. Moore, F. Waldman (1999)
Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia.The American journal of pathology, 154 6
A. Balmain (2002)
Cancer: New-age tumour suppressorsNature, 417
P. Koivisto, J. Kononen, C. Palmberg, T. Tammela, E. Hyytinen, J. Isola, J. Trapman, K. Cleutjens, A. Noordzij, T. Visakorpi, O. Kallioniemi (1997)
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.Cancer research, 57 2
A. Klein, A. Kessel, G. Grosveld, C. Bartram, A. Hagemeijer, D. Bootsma, N. Spurr, N. Heisterkamp, J. Groffen, J. Stephenson (1982)
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemiaNature, 300
H. Lassus, M. Laitinen, M. Anttonen, M. Heikinheimo, L. Aaltonen, O. Ritvos, R. Butzow (2001)
Comparison of Serous and Mucinous Ovarian Carcinomas: Distinct Pattern of Allelic Loss at Distal 8p and Expression of Transcription Factor GATA-4Laboratory Investigation, 81
L. Michel, Vasco Liberal, Anupam Chatterjee, Regina Kirchwegger, B. Pasche, W. Gerald, M. Dobles, P. Sorger, V. Murty, R. Benezra (2001)
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cellsNature, 409
Kyoung-Mee Kim, D. Shibata (2002)
Methylation reveals a niche: stem cell succession in human colon cryptsOncogene, 21
A. Namazie, S. Alavi, O. Olopade, G. Pauletti, Neema Aghamohammadi, Mazda Aghamohammadi, Jeffrey Gornbein, T. Calcaterra, D. Slamon, Marilene Wang, Marilene Wang, E. Srivatsan (2002)
Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck TumorsThe Laryngoscope, 112
J. Schlegel, G. Stumm, H. Scherthan, T. Bocker, H. Zirngibl, J. Rüschoff, F. Hofstädter (1995)
Comparative genomic in situ hybridization of colon carcinomas with replication error.Cancer research, 55 24
S. Knuutila, K. Autio, Y. Aalto (2000)
Online access to CGH data of DNA sequence copy number changes.The American journal of pathology, 157 2
K. Haigis, J. Caya, M. Reichelderfer, W. Dove (2002)
Intestinal adenomas can develop with a stable karyotype and stable microsatellitesProceedings of the National Academy of Sciences of the United States of America, 99
J. Rowley (1998)
The critical role of chromosome translocations in human leukemias.Annual review of genetics, 32
C. Eisenberger, M. Schoenberg, C. Enger, S. Hortopan, S. Shah, N. Chow, F. Marshall, D. Sidransky (1999)
Diagnosis of renal cancer by molecular urinalysis.Journal of the National Cancer Institute, 91 23
M. Koshiji, Y. Yonekura, Takamichi Saito, K. Yoshioka (2002)
Microsatellite analysis of fecal DNA for colorectal cancer detection *Journal of Surgical Oncology, 80
A. D’Assoro, W. Lingle, J. Salisbury (2002)
Centrosome amplification and the development of cancerOncogene, 21
R. Maser, R. DePinho (2002)
Connecting chromosomes, crisis, and cancer.Science, 297 5581
D. Cahill, C. Lengauer, Jian Yu, G. Riggins, J. Willson, S. Markowitz, K. Kinzler, B. Vogelstein (1998)
Mutations of mitotic checkpoint genes in human cancersNature, 392
S. Baker, Antonette Preisinger, J. Jessup, C. Paraskeva, S. Markowitz, J. Willson, S. Hamilton, B. Vogelstein (1990)
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.Cancer research, 50 23
P. Jallepalli, C. Lengauer (2001)
Chromosome segregation and cancer: cutting through the mysteryNature Reviews Cancer, 1
J. Jing, Jason Reed, John Huang, John Huang, Xinghua Hu, V. Clarke, Joanne Edington, Dan Housman, T. Anantharaman, E. Huff, B. Mishra, B. Porter, Alexander Shenker, Estarose Wolfson, C. Hiort, Ron Kantor, C. Aston, D. Schwartz (1998)
Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules.Proceedings of the National Academy of Sciences of the United States of America, 95 14
W. Hahn, C. Counter, A. Lundberg, R. Beijersbergen, M. Brooks, R. Weinberg (1999)
Creation of human tumour cells with defined genetic elementsNature, 400
PP Massion (2002)
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathwayCancer Res., 62
N. Hastie, M. Dempster, M. Dunlop, A. Thompson, D. Green, R. Allshire (1990)
Telomere reduction in human colorectal carcinoma and with ageingNature, 346
I. Sokolova, K. Halling, Robert Jenkins, H. Burkhardt, Reid Meyer, S. Seelig, Walter King (2000)
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.The Journal of molecular diagnostics : JMD, 2 3
K. Rudolph, Melissa Millard, M. Bosenberg, R. DePinho (2001)
Telomere dysfunction and evolution of intestinal carcinoma in mice and humansNature Genetics, 28
L. Thompson, D. Schild (2002)
Recombinational DNA repair and human disease.Mutation research, 509 1-2
T. Kuukasjärvi, R. Karhu, M. Tanner, M. Kähkönen, A. Schäffer, N. Nupponen, S. Pennanen, A. Kallioniemi, O. Kallioniemi, J. Isola (1997)
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.Cancer research, 57 8
D. Banerjee, P. Mayer‐Kuckuk, G. Capiaux, T. Budak-Alpdogan, R. Gorlick, J. Bertino (2002)
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.Biochimica et biophysica acta, 1587 2-3
A. Snijders, N. Nowak, R. Segraves, S. Blackwood, Nils Brown, J. Conroy, G. Hamilton, A. Hindle, B. Huey, Karen Kimura, Sindy Law, K. Myambo, J. Palmer, B. Ylstra, J. Yue, J. Gray, Ajay Jain, D. Pinkel, D. Albertson (2001)
Assembly of microarrays for genome-wide measurement of DNA copy numberNature Genetics, 29
S. Herblot, P. Aplan, T. Hoang (2002)
Gradient of E2A Activity in B-Cell DevelopmentMolecular and Cellular Biology, 22
V. Knezević, C. Leethanakul, V. Bichsel, Jennifer Worth, V. Prabhu, J. Gutkind, L. Liotta, P. Munson, Emanuel III, D. Krizman (2001)
Proteomic profiling of the cancer microenvironment by antibody arraysPROTEOMICS, 1
D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W. Kuo, Chira Chen, Y. Zhai, S. Dairkee, B. Ljung, J. Gray, D. Albertson (1998)
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 20
K. Quon, A. Berns (2001)
Haplo-insufficiency? Let me count the ways.Genes & development, 15 22
L. Donehower, L. Godley, Claudio Aldaz, R. Pyle, Y. Shi, D. Pinkel, J. Gray, A. Bradley, D. Medina, H. Varmus (1995)
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.Genes & development, 9 7
G. Wahl, R. Padgett, G. Stark (1979)
Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.The Journal of biological chemistry, 254 17
Seiji Suzuki, D. Moore, D. Ginzinger, T. Godfrey, Jonathan Barclay, B. Powell, D. Pinkel, C. Zaloudek, K. Lu, G. Mills, A. Berchuck, J. Gray (2000)
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.Cancer research, 60 19
Elizabeth Hyman, P. Kauraniemi, S. Hautaniemi, M. Wolf, S. Mousses, E. Rozenblum, M. Ringnér, G. Sauter, O. Monni, A. Elkahloun, O. Kallioniemi, A. Kallioniemi (2002)
Impact of DNA amplification on gene expression patterns in breast cancer.Cancer research, 62 21
L. Harrington, M. Robinson (2002)
Telomere dysfunction: multiple paths to the same endOncogene, 21
H. Davies, G. Bignell, Charles Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, Mathew Garnett, W. Bottomley, Neil Davis, E. Dicks, Rebecca Ewing, Yvonne Floyd, K. Gray, S. Hall, R. Hawes, Jaime Hughes, Vivian Kosmidou, A. Menzies, Catherine Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, Rebecca Wilson, H. Jayatilake, B. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. Riggins, D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, Judy Ho, Suet Leung, Siu Yuen, Barbara Weber, H. Seigler, T. Darrow, H. Paterson, R. Marais, Christopher Marshall, R. Wooster, Michael Stratton, P. Futreal (2002)
Mutations of the BRAF gene in human cancerNature, 417
R. Schimke, R. Kaufman, F. Alt, R. Kellems (1978)
Gene amplification and drug resistance in cultured murine cells.Science, 202 4372
F. Waldman, S. Devries, K. Chew, D. Moore, K. Kerlikowske, B. Ljung (2000)
Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences.Journal of the National Cancer Institute, 92 4
W. Hanna (2001)
Testing for HER2 StatusOncology, 61
A. Snijders, J. Fridlyand, D. Mans, R. Segraves, Ajay Jain, D. Pinkel, D. Albertson (2003)
Shaping of tumor and drug-resistant genomes by instability and selectionOncogene, 22
C. Klein, O. Schmidt-Kittler, J. Schardt, K. Pantel, M. Speicher, G. Riethmüller (1999)
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells.Proceedings of the National Academy of Sciences of the United States of America, 96 8
Justin Smith, B. Alderete, Y. Minn, T. Borell, A. Perry, G. Mohapatra, Sandra Hosek, D. Kimmel, J. O'fallon, A. Yates, B. Feuerstein, P. Burger, B. Scheithauer, R. Jenkins (1999)
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeOncogene, 18
D. Morris, J. Dutra (1997)
Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.Virology, 238 1
L. Veer, H. Dai, M. Vijver, Yudong He, A. Hart, M. Mao, H. Peterse, K. Kooy, M. Marton, A. Witteveen, G. Schreiber, R. Kerkhoven, C. Roberts, P. Linsley, R. Bernards, S. Friend (2002)
Gene expression profiling predicts clinical outcome of breast cancerNature, 415
C. Poremba, W. Böcker, H. Willenbring, K. Schäfer, F. Otterbach, H. Bürger, R. Diallo, B. Dockhorn‐Dworniczak (1998)
Telomerase activity in human proliferative breast lesions.International journal of oncology, 12 3
E. Schröck, S. Manoir, T. Veldman, B. Schoell, J. Wienberg, M. Ferguson-Smith, Yihang Ning, D. Ledbetter, I. Bar-Am, D. Soenksen, Y. Garini, T. Ried (1996)
Multicolor Spectral Karyotyping of Human ChromosomesScience, 273
D. Zimonjic, M. Brooks, N. Popescu, R. Weinberg, W. Hahn (2001)
Derivation of human tumor cells in vitro without widespread genomic instability.Cancer research, 61 24
P. Cutler (2003)
Protein arrays: The current state‐of‐the‐artPROTEOMICS, 3
P. Soulié, E. Fourme, R. Hamelin, B. Asselain, R. Salmon, B. Dutrillaux, M. Muleris (1999)
TP53 status and gene amplification in human colorectal carcinomas.Cancer genetics and cytogenetics, 115 2
M. Muleris, A. Dutrillaux, S. Olschwang, R. Salmon, B. Dutrillaux (1995)
Predominance of normal karyotype in colorectal tumors from hereditary non‐polyposis colorectal cancer patientsGenes, 14
Chromosome aberrations in human solid tumors are hallmarks of gene deregulation and genome instability. This review summarizes current knowledge regarding aberrations, discusses their functional importance, suggests mechanisms by which aberrations may form during cancer progression and provides examples of clinical advances that have come from studies of chromosome aberrations.
Nature Genetics – Springer Journals
Published: Jul 30, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.